Stocks to sell

Cassava Sciences (NASDAQ:SAVA) stock is in a tailspin after a lab denied it had prepared recent results for the biotech’s experimental Alzheimer’s disease treatment. Source: pathdoc / Shutterstock.com Following the news, Cassava shares fell approximately 50%, eliminating roughly $2.4 billion of value over three trading days. The rejection contradicts a statement from Cassava that Quanterix

My feelings about DiDi Global Inc. (NYSE:DIDI) can probably be summed up by saying it’s riskier than a new driver tackling “Death Road.” Otherwise known as the North Yungas Road in Bolivia, it’s one of the most dangerous roads on earth. As Lookers states in an article, “It has been estimated that around 200-300 people

It makes little sense for Ocugen (NASDAQ:OCGN) stock to remain at $7.50 or so per share. Source: Shutterstock As you may know, the company is working to bring Covaxin, developed by India-based Bharat Biotech, to North America. Over time, though, it has become clearer that this company’s Covid-19 vaccine gambit has slim chances of paying

“The future of sports is electronic. The future of sports is mobile. The future of sports is now.” This is what Skillz Inc. (NYSE:SKLZ) says in a video about how it works. But if this is the future of sports, then why did SKLZ stock fall over 45% year to date to Monday’s close of

Context Logic (NASDAQ:WISH) stock has had a rough few weeks. Source: sdx15 / Shutterstock.com The company posted dismal second-quarter results and expected the slowdown to continue in the third quarter. Consequently, WISH stock is down more than 30% this month. Long-term growth drivers are in place, but its troubling fundamentals and business risks have me

This is certainly an odd economy. On one hand, the delta variant is a dark shadow over how long economic expansion lasts. On the other, the economy is booming and oil stocks have gone from zeros to heroes in the past year. The S&P Global Oil Index, which measures the performance of 120 of the

It remains clear that Jumia Technologies (NYSE:JMIA) and its stock are undergoing growing pains.  Source: Christopher Penler / Shutterstock.com Is it an interesting e-commerce company? Definitely. Comparisons between it and Amazon (NASDAQ:AMZN) abound. Thus, pundits have dubbed it the Amazon of Africa. Let’s be clear here: It has the potential to become to Africa what

DiDi Global (NYSE:DIDI) could easily fall quite significantly to the value of just its non-China operations, plus its net cash (as long as that cash is not in China). This is because Chinese regulators have placed the company under dire restrictions. If that happens, I estimate that DIDI stock would be worth no more than

Right now everyone loves Square (NASDAQ:SQ) stock. Source: Jonathan Weiss / Shutterstock.com The company only came public in 2015, at a market cap of $2.9 billion. Today that number is right around $124 billion. At its current value Square is the third most valuable payment outfit, behind only MasterCard (NYSE:MA) and Visa (NYSE:V). But it

How far can a small medical devices company take a celebrity endorsement? The shares of veterinary diagnostics company Zomedica (NYSEAMERICAN:ZOM) surged after an endorsement from Tiger King celebrity Carole Baskin. In response, meme traders bid ZOM stock up sharply. Since the short interest in ZOM stock is high, the news created a dramatic short squeeze. Source:

Clover Health (NASDAQ:CLOV) has been one of the year’s biggest disappointments. The so-called King of SPACs (special purpose acquisition companies), Chamath Palihapitiya, took the health insurer public via one of his Social Capital Hedosophia SPACs. CLOV stock shares almost immediately tumbled after short sellers revealed that it had failed to disclose a government investigation into

Outlier Covid-19 vaccine play Ocugen (NASDAQ:OCGN) stock has been on a negative run in the past three months, losing about 17% of its value. Source: Shutterstock The company failed to gain an emergency use authorization (EUA) from the FDA for Covaxin, the Indian variant of the coronavirus vaccine. Moreover, its partner firm Bharat Biotech is

If you think Carnival (NYSE:CCL) and CCL stock is a good bet at almost $24, you might want to think again. Covid-19 is still very much still an “unwanted passenger” on its cruise ships. As a result, a resumption to pre-pandemic cruising — as well as improvements in the CCL stock price — seem like they’re

This is my first time writing about Novavax (NASDAQ:NVAX) and the more I learn about the company, I can’t help but think about Inception, the Leonardo DiCaprio movie about dreams within dreams. A lot of the discussion around Novavax’s Covid-19 vaccine feels like living in that film’s impossible dream worlds. People buying NVAX stock are believing

News of one of its vehicles being involved in a fatal autopilot crash may be making the rounds, but expect it to be at most only a brief hiccup. With Nio (NYSE:NIO) stock, it’s other factors that you should worry about. Source: Sundry Photography / Shutterstock.com As you may know, China’s regulatory crackdown has been

GameStop (NYSE:GME) remains one of the year’s most remarkable stock market stories. GME stock enjoyed not one but two historic short squeezes, leading to windfall profits for longs and incredible pain for skeptics such as Melvin Capital. Source: rblfmr / Shutterstock.com However, the fun may be winding down for GameStop. Shares have been sliding for

I have been consistently negative on FuelCell Energy (NASDAQ:FCEL) stock. I wrote about it on Feb. 2 when it was around $21.43 and on May 27 at $9.84 that FCEL stock would likely keep falling. And Monday it closed at $6.14 but I continue to argue that it is overvalued. Source: Kaca Skokanova/Shutterstock You might

Cassava Sciences (NASDAQ:SAVA) is a biotech company with an important goal: fighting Alzheimer’s disease. It has several treatments in development, but is SAVA stock worth adding to your portfolio? Source: Shutterstock Obviously, I want this company to succeed; I witnessed a family friend’s battle with Alzheimer’s disease, and I would love for Cassava to succeed

Stock market gauges such as the S&P 500 index and Nasdaq 100 index continue to sit at or near all-time highs. While leading stocks continue to perform admirably, many companies have had a difficult summer. Small-cap firms, special purpose acquisition companies (SPACs), and unprofitable tech companies have seen their shares dive. If the corrections spread,

A spate of positive developments may be helping to keep AMC Entertainment (NYSE:AMC) stock steady. But should investors take this as a sign that it’s wise to buy in now, ahead of this “meme stock” favorite of the Reddit trading community surging higher once again? Source: viewimage / Shutterstock.com Not so fast. Its recent resiliency